Ado-trastuzumab emtansine and Insulin Detemir (Vials)
Determining the interaction of Ado-trastuzumab emtansine and Insulin Detemir (Vials) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ado-trastuzumab emtansine
Brand name: Kadcyla
Synonyms: Ado-Trastuzumab Emtansine
Generic Name: insulin detemir
Brand name: Levemir, Levemir FlexPen, Levemir PenFill, Levemir InnoLet, Levemir FlexTouch
Synonyms: Insulin detemir, Insulin Detemir
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ado-trastuzumab emtansine-Insulin detemir Subcutaneous
- Ado-trastuzumab emtansine-Insulin glargine
- Ado-trastuzumab emtansine-Insulin Glargine (U-100) Cartridge Systems and Pens
- Ado-trastuzumab emtansine-Insulin Glargine (U-100) Vials
- Ado-trastuzumab emtansine-Insulin Glargine (U-300) Pens
- Ado-trastuzumab emtansine-Insulin glargine and lixisenatide
- Insulin Detemir (Vials)-Ado-trastuzumab emtansine Intravenous
- Insulin Detemir (Vials)-Adox Pak 2/100
- Insulin Detemir (Vials)-Adoxa
- Insulin Detemir (Vials)-Adoxa CK
- Insulin Detemir (Vials)-Adoxa Pak
- Insulin Detemir (Vials)-Adoxa Pak 1/100